Pfizer shares hit 52-week high after firm claims its vaccine is over 90% effective

Pfizer Inc. did not provide any more details about those cases and cautioned the initial protection rate might change by the time the study ends. Even revealing such early data is highly unusual.

Read Full Story on MoneyControl

Enter your email address:


We will be happy to hear your thoughts

      Leave a reply

      IndiaClicking - Buzzing News & Stocks